Cargando…

Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells

Besides playing a crucial role in immune surveillance, human leukocyte antigens (HLA) possess numerous non-immune functions involved in cell communication. In the present study, screening of a panel of HLA class I- and HLA class II-specific monoclonal antibodies (mAbs) for their effects on the metab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peppicelli, Silvia, Ruzzolini, Jessica, Andreucci, Elena, Bianchini, Francesca, Kontos, Filippos, Yamada, Teppei, Ferrone, Soldano, Calorini, Lido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770395/ https://www.ncbi.nlm.nih.gov/pubmed/31454998 http://dx.doi.org/10.3390/cancers11091249

Ejemplares similares

Cancer Glycolytic Dependence as a New Target of Olive Leaf Extract
por: Ruzzolini, Jessica, et al.
Publicado: (2020)

FDG uptake in cancer: a continuing debate
por: Peppicelli, Silvia, et al.
Publicado: (2020)

Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry
por: Andreucci, Elena, et al.
Publicado: (2022)

The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells
por: Peppicelli, Silvia, et al.
Publicado: (2020)

SOX2 as a novel contributor of oxidative metabolism in melanoma cells
por: Andreucci, Elena, et al.
Publicado: (2018)

Anoikis Resistance as a Further Trait of Acidic-Adapted Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2019)

Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2022)

The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells
por: Andreucci, Elena, et al.
Publicado: (2020)

Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies
por: Ruzzolini, Jessica, et al.
Publicado: (2018)

Inflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasis
por: PEPPICELLI, SILVIA, et al.
Publicado: (2014)

The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
por: Andreucci, Elena, et al.
Publicado: (2018)

Nintedanib-αVβ6 Integrin Ligand Conjugates Reduce TGFβ-Induced EMT in Human Non-Small Cell Lung Cancer
por: Andreucci, Elena, et al.
Publicado: (2023)

A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer
por: Ruzzolini, Jessica, et al.
Publicado: (2019)

uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells
por: Andreucci, Elena, et al.
Publicado: (2022)

Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approach
por: Peppicelli, Silvia, et al.
Publicado: (2015)

miR-214-Enriched Extracellular Vesicles Released by Acid-Adapted Melanoma Cells Promote Inflammatory Macrophage-Dependent Tumor Trans-Endothelial Migration
por: Andreucci, Elena, et al.
Publicado: (2022)

EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells
por: Laurenzana, Anna, et al.
Publicado: (2019)

Oleuropein-Rich Leaf Extract as a Broad Inhibitor of Tumour and Macrophage iNOS in an Apc Mutant Rat Model
por: Ruzzolini, Jessica, et al.
Publicado: (2021)

An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy
por: Peri, Sara, et al.
Publicado: (2022)

CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines
por: Biagioni, Alessio, et al.
Publicado: (2021)

Oleuropein, a Bioactive Compound from Olea europaea L., as a Potential Preventive and Therapeutic Agent in Non-Communicable Diseases
por: Nediani, Chiara, et al.
Publicado: (2019)

uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells
por: Biagioni, Alessio, et al.
Publicado: (2020)

HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab
por: Ladányi, Andrea, et al.
Publicado: (2022)

Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer
por: Michelakos, Theodoros, et al.
Publicado: (2022)

Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions
por: Calorini, Lido, et al.
Publicado: (2010)

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma
por: Mehta, Akash M., et al.
Publicado: (2007)

Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma
por: Ladányi, Andrea, et al.
Publicado: (2020)

Triazole RGD antagonist reverts TGFβ1-induced endothelial-to-mesenchymal transition in endothelial precursor cells
por: Bianchini, Francesca, et al.
Publicado: (2016)

High frequency of HLA class I antigen processing machinery (APM) component upregulation in primary hepatocellular carcinoma tumors
por: Grizzi, Fabio, et al.
Publicado: (2013)

Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma
por: Ritter, Cathrin, et al.
Publicado: (2017)

Selective Histocompatibility Leukocyte Antigen (Hla)-A2 Loss Caused by Aberrant Pre-mRNA Splicing in 624mel28 Melanoma Cells
por: Wang, Zhigang, et al.
Publicado: (1999)

Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits
por: Calvani, Maura, et al.
Publicado: (2016)

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

Nintedanib-Containing Dual Conjugates Targeting α(V)β(6) Integrin and Tyrosine Kinase Receptors as Potential Antifibrotic Agents
por: Bugatti, Kelly, et al.
Publicado: (2022)

The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy
por: Rovida, Elisabetta, et al.
Publicado: (2014)

HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors
por: Sottile, Rosa, et al.
Publicado: (2015)

Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma Tumors
por: Georgopoulos, Apostolos P, et al.
Publicado: (2023)

STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients
por: Srivastava, Raghvendra M, et al.
Publicado: (2013)

AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma
por: Conteduca, Giuseppina, et al.
Publicado: (2016)

Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma
por: Norton, Duncan L., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rebbhu7sis5uk3pvouorf5rcs6